VIBATIV Pregnancy Registry

Withdrawn before enrolling

Conditions studied: Pregnancy

In brief

The purpose of this registry is to evaluate the outcome of pregnancy in women exposed to VIBATIV at any time during pregnancy. There are no mandated physician visits for the registry.

Key facts

Study ID

NCT01130324

Run by

Cumberland Pharmaceuticals

People needed

0

Starts

2009-11-01

Expected to finish

2020-10-01

Last updated by the study team

2020-10-19

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients who were exposed to VIBATIV at any time during pregnancy
• Outcome of pregnancy is unknown at the time of enrollment

Where it is running

• Cumberland Pharmaceuticals Inc. — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.